NewAmsterdam Pharma

(NASDAQ) NAMS

Current Price$35.44

Market Cap$4.14B

Since IPO (2021)+228%

5 Year+261%

1 Year+90%

1 Month+4%

NewAmsterdam Pharma Financials at a Glance

Market Cap

$4.14B

Revenue (TTM)

$22.57M

Net Income (TTM)

$212.73M

EPS (TTM)

$-1.80

P/E Ratio

-19.64

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$35.44

Volume

42,005

Open

$36.36

Price

$35.44

Volume

42,005

Open

$36.36

Previous Close

$35.44

Daily Range

$35.08 - $36.45

52-Week Range

$16.79 - $42.20

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$35.44

Volume

42,005

Open

$36.36

Previous Close

$35.44

Daily Range

$35.08 - $36.45

52-Week Range

$16.79 - $42.20

NAMS News

NewAmsterdam (NAMS) Q2 Revenue Jumps 49%

Motley Fool Markets TeamAug 6, 2025

Doctor with senior man_GettyImages-1147479334

Why Shares of NewAmsterdam Pharma Were Plummeting on Wednesday

James HalleyJun 7, 2023

NAMS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NewAmsterdam Pharma

Industry

Biotechnology

Sector

Health Care

Employees

100

CEO

Michael H. Davidson, MD

Website

www.newamsterdampharma.com

Headquarters

Naarden, 1411 DC, NL

NAMS Financials

Key Financial Metrics (TTM)

Gross Margin

98%

Operating Margin

-10%

Net Income Margin

-9%

Return on Equity

-29%

Return on Capital

-32%

Return on Assets

-29%

Earnings Yield

-5.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.14B

Shares Outstanding

116.90M

Volume

42.01K

Avg. Volume

1.08M

Financials (TTM)

Gross Profit

$22.44M

Operating Income

$225.68M

EBITDA

$242.32M

Operating Cash Flow

$147.78M

Capital Expenditure

$246.00K

Free Cash Flow

$148.03M

Cash & ST Invst.

$636.24M

Total Debt

$202.00K

NewAmsterdam Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$3.04M

+2.1%

Gross Profit

$2.54M

-14.7%

Gross Margin

83.55%

N/A

Market Cap

$4.14B

N/A

Market Cap/Employee

$60.93M

N/A

Employees

N/A

Net Income

$48.44M

-22.6%

EBITDA

$58.36M

+15.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$636.08M

-21.3%

Accounts Receivable

$8.22M

+409.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$23.00K

-90.9%

Return on Assets

-29.04%

N/A

Return on Invested Capital

-32.35%

N/A

Free Cash Flow

$30.64M

+16.0%

Operating Cash Flow

$30.60M

+16.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LGNDLigand Pharmaceuticals Incorporated

LGNDLigand Pharmaceuticals Incorporated$213.21-2.63%

CRNXCrinetics Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.$36.77-4.02%

AKROAkero Therapeutics, Inc.

AKROAkero Therapeutics, Inc.$54.65+0.00%

VKTXViking Therapeutics, Inc.

VKTXViking Therapeutics, Inc.$30.27-4.54%

SLNOSoleno Therapeutics, Inc.

SLNOSoleno Therapeutics, Inc.$53.01+0.04%

IMVTImmunovant, Inc.

IMVTImmunovant, Inc.$27.49-5.08%

CGONCG Oncology, Inc. Common stock

CGONCG Oncology, Inc. Common stock$66.93-3.75%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

FFord Motor Company

FFord Motor Company$13.40-0.07%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

FIGFigma

FIGFigma$22.92+0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

Questions About NAMS

What is the current price of NewAmsterdam Pharma?

NewAmsterdam Pharma is trading at $35.44 per share.

What is the 52-week range for NewAmsterdam Pharma?

Over the past 52 weeks, NewAmsterdam Pharma has traded between $16.79 and $42.21.

How much debt does NewAmsterdam Pharma have?

As of the most recent reporting period, NewAmsterdam Pharma reported total debt of $23,000.

How much cash does NewAmsterdam Pharma have on hand?

NewAmsterdam Pharma reported $458.94M in cash and cash equivalents in its most recent financial results.

What is NewAmsterdam Pharma’s dividend yield?

NewAmsterdam Pharma does not currently have a dividend yield.

NewAmsterdam Pharma

NewAmsterdam Pharma Financials at a Glance

NAMS News

NewAmsterdam (NAMS) Q2 Revenue Jumps 49%

Why Shares of NewAmsterdam Pharma Were Plummeting on Wednesday

NAMS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NewAmsterdam Pharma

NAMS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NewAmsterdam Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NAMS

What is the current price of NewAmsterdam Pharma?

What is the 52-week range for NewAmsterdam Pharma?

How much debt does NewAmsterdam Pharma have?

How much cash does NewAmsterdam Pharma have on hand?

What is NewAmsterdam Pharma’s dividend yield?

Premium Investing Services